DeltaNp73 transcription factors modulate cell survival and tumor development

Cell Cycle

Volumn 9, Issue 8, 2010, Pages 1523-1527

  Ravni, Aurélia ^a   Tissir, Fadel ^a   Goffinet, André M ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Apoptosis; Cajal retzius cells; Fibrosarcoma; Methycholanthrene; Oncogene; p73; TAp73

Indexed keywords

3 METHYLCHOLANTHRENE; CRE RECOMBINASE; ENHANCED GREEN FLUORESCENT PROTEIN; PROTEIN P73; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR DELTANP73; UNCLASSIFIED DRUG;

ALLELE; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BRAIN DEVELOPMENT; BRAIN NERVE CELL; CARCINOGENESIS; CELL SURVIVAL; EMBRYO; FEMALE; MALE; MOUSE; NEOPLASM; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; SEX DIFFERENCE; TELENCEPHALON;

MUS;

EID: 77953598591     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.9.8.11291     Document Type: Article

References (36)

1. Tissir F, Ravni A, Achouri Y, Riethmacher D, Meyer G, Goffinet AM. DeltaNp73 regulates neuronal survival in vivo. Proc Natl Acad Sci USA 2009; 106:3-6.
2. Kaghad M, Bonnet H, Yang A, Creancier L, Biscan JC, Valent A, et al. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 1997; 90:809-19. (Pubitemid 27357971)
3. Flores ER, Sengupta S, Miller JB, Newman JJ, Bronson R, Crowley D, et al. Tumor predisposition in mice mutant for p63 and p73: evidence for broader tumor suppressor functions for the p53 family. Cancer Cell 2005; 7:363-73. (Pubitemid 40544653)
4. Moll UM, Slade N. p63 and p73: roles in development and tumor formation. Mol Cancer Res 2004; 2:371-86.
5. Yang A, Kaghad M, Caput D, McKeon F. On the shoulders of giants: p63, p73 and the rise of p53. Trends Genet 2002; 18:90-5.
6. Yang A, McKeon F. p63 and p73: p53 mimics, menaces and more. Nat Rev Mol Cell Biol 2000; 1:199-207.
7. Levy D, Adamovich Y, Reuven N, Shaul Y. Yap1 phosphorylation by c-Abl is a critical step in selective activation of proapoptotic genes in response to DNA damage. Mol Cell 2008; 29:350-61. (Pubitemid 351215937)
8. Rossi M, De Laurenzi V, Munarriz E, Green DR, Liu YC, Vousden KH, et al. The ubiquitin-protein ligase Itch regulates p73 stability. EMBO J 2005; 24:836-48. (Pubitemid 40854249)
9. Deyoung MP, Ellisen LW. p63 and p73 in human cancer: defining the network. Oncogene 2007; 26:5169-83.
10. Grob TJ, Novak U, Maisse C, Barcaroli D, Luthi AU, Pirnia F, et al. Human delta Np73 regulates a dominant negative feedback loop for TAp73 and p53. Cell Death Differ 2001; 8:1213-23. (Pubitemid 34048476)
11. Emmrich S, Wang W, John K, Li W, Putzer BM. Antisense gapmers selectively suppress individual oncogenic p73 splice isoforms and inhibit tumor growth in vivo. Mol Cancer 2009; 8:61.
12. Stiewe T, Zimmermann S, Frilling A, Esche H, Putzer BM. Transactivation-deficient DeltaTA-p73 acts as an oncogene. Cancer Res 2002; 62:3598-602.
13. Meyer G, Cabrera Socorro A, Perez Garcia CG, Martinez Millan L, Walker N, Caput D. Developmental roles of p73 in Cajal-Retzius cells and cortical patterning. J Neurosci 2004; 24:9878-87. (Pubitemid 39463568)
14. Yang A, Walker N, Bronson R, Kaghad M, Oosterwegel M, Bonnin J, et al. p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours. Nature 2000; 404:99-103. (Pubitemid 30143141)
15. Tomasini R, Tsuchihara K, Tsuda C, Lau SK, Wilhelm M, Ruffini A, et al. TAp73 regulates the spindle assembly checkpoint by modulating BubR1 activity. Proc Natl Acad Sci USA 2009; 106:797-802.
16. Tomasini R, Tsuchihara K, Wilhelm M, Fujitani M, Rufini A, Cheung CC, et al. TAp73 knockout shows genomic instability with infertility and tumor suppressor functions. Genes Dev 2008.
17. Abbott LC, Jacobowitz DM. Developmental expression of calretinin-immunoreactivity in the thalamic eminence of the fetal mouse. Int J Dev Neurosci 1999; 17:331-45.
18. Mitrofanis J, Baker GE. Development of the thalamic reticular and perireticular nuclei in rats and their relationship to the course of growing corticofugal and corticopetal axons. J Comp Neurol 1993; 338:575-87. (Pubitemid 23237410)
19. Hirata T, Li P, Lanuza GM, Cocas LA, Huntsman MM, Corbin JG. Identification of distinct telencephalic progenitor pools for neuronal diversity in the amygdala. Nat Neurosci 2009; 12:141-9.
20. Frotscher M, Seress L, Abraham H, Heimrich B. Early generated Cajal-Retzius cells have different functions in cortical development. Symp Soc Exp Biol 2001; 43-9.
21. Bielle F, Griveau A, Narboux-Neme N, Vigneau S, Sigrist M, Arber S, et al. Multiple origins of Cajal-Retzius cells at the borders of the developing pallium. Nat Neurosci 2005; 8:1002-12. (Pubitemid 41061510)
22. Lavdas AA, Grigoriou M, Pachnis V, Parnavelas JG. The medial ganglionic eminence gives rise to a population of early neurons in the developing cerebral cortex. J Neurosci 1999; 19:7881-8. (Pubitemid 30225786)
23. Meyer G, Perez-Garcia CG, Abraham H, Caput D. Expression of p73 and Reelin in the developing human cortex. J Neurosci 2002; 22:4973-86. (Pubitemid 37465612)
24. Meyer G, Wahle P. The paleocortical ventricle is the origin of reelin-expressing neurons in the marginal zone of the foetal human neocortex. Eur J Neurosci 1999; 11:3937-44. (Pubitemid 29537573)
25. Soda T, Nakashima R, Watanabe D, Nakajima K, Pastan I, Nakanishi S. Segregation and coactivation of developing neocortical layer 1 neurons. J Neurosci 2003; 23:6272-9. (Pubitemid 36875629)
26. Takiguchi-Hayashi K, Sekiguchi M, Ashigaki S, Takamatsu M, Hasegawa H, Suzuki-Migishima R, et al. Generation of reelin-positive marginal zone cells from the caudomedial wall of telencephalic vesicles. J Neurosci 2004; 24:2286-95. (Pubitemid 38314560)
27. Pozniak CD, Barnabe-Heider F, Rymar VV, Lee AF, Sadikot AF, Miller FD. p73 is required for survival and maintenance of CNS neurons. J Neurosci 2002; 22:9800-9. (Pubitemid 35332864)
28. Melino G, De Laurenzi V, Vousden KH. p73: Friend or foe in tumorigenesis. Nat Rev Cancer 2002; 2:605-15.
29. Dominguez G, Silva JM, Silva J, Garcia JM, Sanchez A, Navarro A, et al. Wild type p73 overexpression and high-grade malignancy in breast cancer. Breast Cancer Res Treat 2001; 66:183-90. (Pubitemid 32675020)
30. Guan M, Peng HX, Yu B, Lu Y. p73 Overexpression and angiogenesis in human colorectal carcinoma. Jpn J Clin Oncol 2003; 33:215-20. (Pubitemid 43115261)
31. Stiewe T, Putzer BM. Role of p73 in malignancy: tumor suppressor or oncogene? Cell Death Differ 2002; 9:237-45.
32. Duran-Reynals ML, Stanley B. Vaccinia dermal infection and methylcholanthrene in cortisone-treated mice. Science 1961; 134:1984-5.
33. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53:457-81.
34. Schoonjans F, Zalata A, Depuydt CE, Comhaire FH. MedCalc: a new computer program for medical statistics. Comput Methods Programs Biomed 1995; 48:257-62. (Pubitemid 26020881)
35. Bahassi el M, Robbins SB, Yin M, Boivin GP, Kuiper R, van Steeg H, et al. Mice with the CHEK2*1100delC SNP are predisposed to cancer with a strong gender bias. Proc Natl Acad Sci USA 2009; 106:17111-6.
36. Marelli MM, Moretti RM, Januszkiewicz-Caulier J, Motta M, Limonta P. Gonadotropin-releasing hormone (GnRH) receptors in tumors: a new rationale for the therapeutical application of GnRH analogs in cancer patients? Curr Cancer Drug Targets 2006; 6:257-69.